- Home
- BDRX vs NURO Comparison
BDRX vs NURO Comparison
Compare BDRX & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- NURO
- Stock Information
- Founded
- BDRX 2000
- NURO 1996
- Country
- BDRX United Kingdom
- NURO United States
- Employees
- BDRX N/A
- NURO N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- NURO Medical/Dental Instruments
- Sector
- BDRX Health Care
- NURO Health Care
- Exchange
- BDRX Nasdaq
- NURO Nasdaq
- Market Cap
- BDRX 2.8M
- NURO 8.2M
- IPO Year
- BDRX N/A
- NURO N/A
- Fundamental
- Price
- BDRX $5.98
- NURO $4.55
- Analyst Decision
- BDRX Strong Buy
- NURO
- Analyst Count
- BDRX 1
- NURO 0
- Target Price
- BDRX $200.00
- NURO N/A
- AVG Volume (30 Days)
- BDRX 455.7K
- NURO 15.0K
- Earning Date
- BDRX 10-29-2024
- NURO 11-01-2024
- Dividend Yield
- BDRX N/A
- NURO N/A
- EPS Growth
- BDRX N/A
- NURO N/A
- EPS
- BDRX N/A
- NURO N/A
- Revenue
- BDRX $104,895.00
- NURO $4,383,614.00
- Revenue This Year
- BDRX N/A
- NURO N/A
- Revenue Next Year
- BDRX N/A
- NURO N/A
- P/E Ratio
- BDRX N/A
- NURO N/A
- Revenue Growth
- BDRX N/A
- NURO N/A
- 52 Week Low
- BDRX $4.71
- NURO $2.66
- 52 Week High
- BDRX $220.25
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- BDRX 42.77
- NURO 65.06
- Support Level
- BDRX $5.50
- NURO $3.96
- Resistance Level
- BDRX $10.89
- NURO $4.69
- Average True Range (ATR)
- BDRX 1.13
- NURO 0.22
- MACD
- BDRX 0.31
- NURO 0.04
- Stochastic Oscillator
- BDRX 20.55
- NURO 82.35
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.